Latest Articles
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers - koreabiomed.com
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers koreabiomed.com
Published: Jan. 15, 2026, 6:21 a.m.
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News
Published: Jan. 14, 2026, 7:32 p.m.
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity TipRanks
Published: Jan. 14, 2026, 4:33 p.m.
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma springermedicine.com
Published: Jan. 14, 2026, 6:02 a.m.
More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 New York
More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 New York
Published: Jan. 13, 2026, 6:07 p.m.
More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 Los Angeles
More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 Los Angeles
Published: Jan. 13, 2026, 5:02 p.m.
More people are living 5 years after cancer diagnosis, new ACS data shows - ABC30 Fresno
More people are living 5 years after cancer diagnosis, new ACS data shows ABC30 Fresno
Published: Jan. 13, 2026, 5:02 p.m.
ASCO 2025: key highlights in endometrial cancer - springermedicine.com
ASCO 2025: key highlights in endometrial cancer springermedicine.com
Published: Jan. 13, 2026, 5:23 a.m.
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post
Published: Jan. 12, 2026, 6:10 p.m.
‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet
‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment SurvivorNet
Published: Jan. 11, 2026, 6:06 p.m.
Link copied to clipboard!